Skip to main content
Premium Trial:

Request an Annual Quote

ResearchDx, CompanDx Form Partnership Aimed at Companion Dx Development

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – ResearchDx today announced a partnership with CompanDx that it said will result in "a full capability to discover and deliver novel molecular diagnostic tests."

The collaboration draws on ResearchDx's ability to design, produce, and validate tests, and CompanDx's Distiller platform to deliver small composite biomarker signatures from complex data of high dimensionality. As a result, clients will be able to initiate the parallel development of companion diagnostics from the earliest stages of drug development, ResearchDx said.

Financial and other terms of the deal were not disclosed.

Based in Irvine, Calif., ResearchDx is a contract diagnostics organization for the biopharmaceutical and diagnostic industries.

CompanDx is a molecular diagnostics firm based in Nottingham, UK. Earlier this year it and Clinical Reference Laboratory announced a collaboration to develop biomarker panels and companion diagnostics.

The Scan

Just Breathing

A new analysis suggests that most Mycobacterium tuberculosis is spread by aerosols from breathing, rather than by coughing, the New York Times reports.

Just Like This One

NPR reports that the World Health Organization has hired a South African biotech company to recreate mRNA vaccine for SARS-CoV-2 that is similar to the one developed by Moderna.

Slow Start

The Wall Street Journal reports that Biogen's Alzheimer's disease treatment had revenues for July through September that totaled $300,000.

Genome Research Papers on Cancer Chromatin, Splicing in the Thymus, Circular RNAs in Cancer

In Genome Research this week: analysis of bivalent chromatin sites, RBFOX splicing factors' role in thymic epithelial cells, and more.